Lyka Labs is currently trading at Rs 19.85, up by 0.90 points or 4.75% from its previous closing of Rs. 18.95 on the BSE.
The scrip opened at Rs. 19.80 and has touched a high and low of Rs. 19.85 and Rs. 19.40 respectively. So far 150986 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 21.70 on 13-Jun-2014 and a 52 week low of Rs. 9.01 on 04-Dec-2013.
Last one week high and low of the scrip stood at Rs 19.45 and Rs 16.45 respectively. The current market cap of the company is Rs 42.84 crore.
The promoters holding in the company stood at 23.30% while Institutions and Non-Institutions held 4.93% and 71.78% respectively.
Lyka Labs has concluded agreement for sale of formulation manufacturing facilities located at MIDC, Tarapur Industrial Area, Boisar in Maharashtra for consideration of Rs 38.61 crore.
Lyka Labs is engaged in the manufacture of pharmaceutical products. It also manufactures Veterinary products including injections, powders, creams and suspensions. The company offers various surgical disposables, such as syringes, surgical blades, cotton crepe bandage and first aid kits.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1797.80 |
Dr. Reddys Lab | 1213.90 |
Cipla | 1486.30 |
Lupin | 2069.95 |
Zydus Lifesciences | 948.70 |
View more.. |